NMTC - Neuroone Medical Technologies Corp logo

NMTC

Neuroone Medical Technologies Corp

Rev 56xtop 1%5Y
Compare NMTC Hold

NeuroOne Medical Technologies develops high-definition electrodes for continuous EEG and stereoelectroencephalography. Its solutions target epilepsy, Parkinson's disease, and chronic pain through spinal and brain stimulation, drug delivery, and ablation therapies.

โš•๏ธ Healthcare NASDAQ Listed 2017 $ USD
$1,000 invested 5 years ago โ†’$55today

Score Overview

1 Year
Score
Net Growth-98.29%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-17.36%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score4.4
Net Growth28.14%
Net Trend20%
Net Income Consistencyโ€”
Rev Growth56x
Rev Trend60%
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growthโ€”
Net Trend38%
Net Income Consistency
Rev Growthโ€”
Rev Trend44%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Neuroone Medical Technologies Corp has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. NMTC does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-28
$ 1.30โ€”
1 Year2025-09-26
$ 5.51-76.42%
5 Years2021-09-28
$ 23.58-94.49%
All Time2017-09-18
$ 72.00-98.19%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 9M-$ 7M$ 2M
2025$ 12M-$ 3M$ 6M
2024$ 3M-$ 12M$ 1M
2023$ 1M-$ 11M$ 5M
2022$ 171.17K-$ 9M$ 11M
2021$ 178.15K-$ 9M$ 6M
2020$ 1M-$ 13M$ 4M
2019$ 0.00-$ 6M$ 260.75K
2018$ 0.00-$ 6M$ 13.26K
IPO2017$ 0.00$ 522.22K
NMTC - Neuroone Medical Technologies Corp logo

Neuroone Medical Technologies Corp fundamental performance

Between 2020 and 2025, revenue grew from $ 1M to $ 12M and net income went from -$ 13M to -$ 3M. Revenue increased in 3 of those 5 years; net income in 1.

Neuroone Medical Technologies Corp currently holds a 5-year HDB Score of 4.4 out of 10. How the HDB Score is calculated.

Membership

Explore NMTC with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,816 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies